Correlation Between CTT Pharmaceutical and Bionoid Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CTT Pharmaceutical and Bionoid Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CTT Pharmaceutical and Bionoid Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CTT Pharmaceutical Holdings and Bionoid Pharma, you can compare the effects of market volatilities on CTT Pharmaceutical and Bionoid Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CTT Pharmaceutical with a short position of Bionoid Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of CTT Pharmaceutical and Bionoid Pharma.

Diversification Opportunities for CTT Pharmaceutical and Bionoid Pharma

-0.03
  Correlation Coefficient

Good diversification

The 3 months correlation between CTT and Bionoid is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding CTT Pharmaceutical Holdings and Bionoid Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bionoid Pharma and CTT Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CTT Pharmaceutical Holdings are associated (or correlated) with Bionoid Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bionoid Pharma has no effect on the direction of CTT Pharmaceutical i.e., CTT Pharmaceutical and Bionoid Pharma go up and down completely randomly.

Pair Corralation between CTT Pharmaceutical and Bionoid Pharma

Given the investment horizon of 90 days CTT Pharmaceutical Holdings is expected to under-perform the Bionoid Pharma. But the pink sheet apears to be less risky and, when comparing its historical volatility, CTT Pharmaceutical Holdings is 5.25 times less risky than Bionoid Pharma. The pink sheet trades about -0.16 of its potential returns per unit of risk. The Bionoid Pharma is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  25.00  in Bionoid Pharma on August 30, 2024 and sell it today you would lose (14.00) from holding Bionoid Pharma or give up 56.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

CTT Pharmaceutical Holdings  vs.  Bionoid Pharma

 Performance 
       Timeline  
CTT Pharmaceutical 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in CTT Pharmaceutical Holdings are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite fairly conflicting basic indicators, CTT Pharmaceutical demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Bionoid Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bionoid Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with conflicting performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

CTT Pharmaceutical and Bionoid Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CTT Pharmaceutical and Bionoid Pharma

The main advantage of trading using opposite CTT Pharmaceutical and Bionoid Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CTT Pharmaceutical position performs unexpectedly, Bionoid Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionoid Pharma will offset losses from the drop in Bionoid Pharma's long position.
The idea behind CTT Pharmaceutical Holdings and Bionoid Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios